FDA Inspection
Ranier's Compounding LaboratoryRanier's Compounding Laboratory – FDA Inspection, May 22, 2018
Record Details
This FDA Inspection record concerns Ranier's Compounding Laboratory, with an inspection on May 22, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Lisa B. Orr (Issuing Officer)
View Company Profile
ID · 288c59b1-e170-4b86-bbd8-3dadf83d24f3
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1052807
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Ranier's Compounding Laboratory
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2024 | VAI | Philadelphia District Office | Drug Quality Assurance |
| August 16, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 22, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ranier's Compounding Laboratory
- FDA Inspection 1229601 - 2024-02-13
- FDA Inspection 1148893 - 2021-08-16
- FDA Inspection 975474 - 2016-04-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.